Schizoaffective Disorders Completed Phase 4 Trials for Pramlintide (DB01278)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00690235Demonstrate the Effects of Pramlintide on Weight Reduction in SchizophreniaOther